{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:28:47Z","timestamp":1785554927880,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA021765"],"award-info":[{"award-number":["P30 CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11060-020-03415-w","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T13:03:26Z","timestamp":1580735006000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-2664","authenticated-orcid":false,"given":"Christopher L.","family":"Tinkle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Bianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Broniscer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja B.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"issue":"9","key":"3415_CR1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","volume":"19","author":"T Cooney","year":"2017","unstructured":"Cooney T, Lane A, Bartels U et al (2017) Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. Neuro Oncol 19(9):1279\u20131280","journal-title":"Neuro Oncol"},{"issue":"8","key":"3415_CR2","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","volume":"24","author":"SS Donaldson","year":"2006","unstructured":"Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24(8):1266\u20131272","journal-title":"J Clin Oncol"},{"issue":"3","key":"3415_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11060-016-2141-x","volume":"128","author":"SE Veldhuijzen van Zanten","year":"2016","unstructured":"Veldhuijzen van Zanten SE, Cruz O, Kaspers GJ, Hargrave DR, van Vuurden DG, Network SIOPEDIPG (2016) State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature. J Neurooncol 128(3):387\u2013394","journal-title":"J Neurooncol"},{"issue":"3","key":"3415_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241\u2013248","journal-title":"Lancet Oncol"},{"issue":"2","key":"3415_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1148\/93.2.413","volume":"93","author":"TR Whyte","year":"1969","unstructured":"Whyte TR, Colby MY, Layton DD (1969) Radiation therapy of brain-stem tumors. Radiology 93(2):413\u2013416","journal-title":"Radiology"},{"issue":"1","key":"3415_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","volume":"77","author":"R Jalali","year":"2010","unstructured":"Jalali R, Raut N, Arora B et al (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77(1):113\u2013118","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3415_CR7","doi-asserted-by":"crossref","unstructured":"Hibi T, Shitara N, Genka S et al (1992) Radiotherapy for pediatric brain stem glioma: radiation dose, response, and survival. Neurosurgery 31(4):643\u2013650 (discussion 650\u2013641)","DOI":"10.1227\/00006123-199210000-00005"},{"issue":"31","key":"3415_CR8","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1200\/JCO.2010.30.3545","volume":"28","author":"A Broniscer","year":"2010","unstructured":"Broniscer A, Baker JN, Tagen M et al (2010) Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28(31):4762\u20134768","journal-title":"J Clin Oncol"},{"issue":"11","key":"3415_CR9","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-13-0306","volume":"19","author":"A Broniscer","year":"2013","unstructured":"Broniscer A, Baker SD, Wetmore C et al (2013) Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clin Cancer Res 19(11):3050\u20133058","journal-title":"Clin Cancer Res"},{"issue":"15 suppl","key":"3415_CR10","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1200\/jco.2014.32.15_suppl.10064","volume":"32","author":"C Wetmore","year":"2014","unstructured":"Wetmore C, Broniscer A, Turner D et al. First-in-pediatrics phase I study of crenolanib besylate (CP-868,596 \u2013 26) administered during and after radiation therapy (RT) in newly diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent high-grade glioma (HGG). J Clin Oncol 2014; 32(15 suppl):10064","journal-title":"J Clin Oncol"},{"key":"3415_CR11","doi-asserted-by":"crossref","unstructured":"Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C (2016) Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report. Neuro Oncol 18(Suppl 2):ii1\u2013ii12","DOI":"10.1093\/neuonc\/nov267"},{"issue":"3","key":"3415_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ijrobp.2008.05.030","volume":"73","author":"GO Janssens","year":"2009","unstructured":"Janssens GO, Gidding CE, Van Lindert EJ et al (2009) The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. Int J Radiat Oncol Biol Phys 73(3):722\u2013726","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3415_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2014.01.013","volume":"111","author":"MS Zaghloul","year":"2014","unstructured":"Zaghloul MS, Eldebawy E, Ahmed S et al (2014) Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol 111(1):35\u201340","journal-title":"Radiother Oncol"},{"issue":"4","key":"3415_CR14","first-page":"786","volume":"27","author":"KJ Helton","year":"2006","unstructured":"Helton KJ, Phillips NS, Khan RB et al (2006) Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am J Neuroradiol 27(4):786\u2013793","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"3415_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3171\/PED\/2008\/1\/4\/270","volume":"1","author":"KJ Helton","year":"2008","unstructured":"Helton KJ, Weeks JK, Phillips NS et al (2008) Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. J Neurosurg Pediatr 1(4):270\u2013276","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"3415_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nou104","volume":"17","author":"MH Jansen","year":"2015","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E et al (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17(1):160\u2013166","journal-title":"Neuro Oncol"},{"issue":"19","key":"3415_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol 36(19):1963\u20131972","journal-title":"J Clin Oncol"},{"key":"3415_CR18","unstructured":"Massimino M (2015) Study of re-irradiation at relapse versus RT and multiple elective RT courses (DIPG). Clinical Trials.gov Identifier: NCT03620032"},{"issue":"11","key":"3415_CR19","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group. J Clin Oncol 28(11):1963\u20131972","journal-title":"J Clin Oncol"},{"issue":"7","key":"3415_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","volume":"8","author":"DR Macdonald","year":"1990","unstructured":"Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7):1277\u20131280","journal-title":"J Clin Oncol"},{"issue":"5","key":"3415_CR21","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/neuonc\/nox029","volume":"19","author":"L Nayak","year":"2017","unstructured":"Nayak L, DeAngelis LM, Brandes AA et al (2017) The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol 19(5):625\u2013635","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03415-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03415-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:17:57Z","timestamp":1612225077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03415-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3415"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03415-w","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"16 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}